ASXL1 and myeloproliferative neoplasm: The MDS phenotype in Asxl1 haploinsufficient mice at 6-12 months (Abdel-Wahab et al., 2013) was different from the very penetrant and early MPN phenotype (5 months) that we observed in the asxl1 mutant zebrafish model.